Drugs

FDA Warns Consumers Not to Use Viansilk’s “Crema Piel De Seda” (“Silky Skin Cream”)

en Español

 

The Food and Drug Administration (FDA) is warning consumers not to purchase or use a skin whitening cream called “Crema Piel De Seda,” due to the risk of mercury poisoning.    

FDA laboratory analysis identified mercury in the product.  Exposure to mercury can cause serious health problems, such as kidney and nervous system damage.  Mercury can also interfere with brain development in children. Signs and symptoms of mercury poisoning include, irritability, shyness, tremors, changes in vision or hearing, memory problems, depression, and numbness and tingling in hands, feet or around the mouth. 

Crema Piel De Seda skin cream is labeled in Spanish and is sold primarily in Spanish-speaking communities in the U.S.  The product can be found in flea markets and local retail outlets, and is promoted to whiten skin, treat acne, and remove warts and various skin blemishes.  The product is manufactured in Mexico by Viansilk (www.viansilk.comdisclaimer icon).  

Consumers are urged to immediately discontinue using Viansilk’s Crema Piel De Seda.  Anyone who has used this product should thoroughly wash their hands and any other parts of the body that have come in contact with the product, and should contact their health care professional or medical care clinic for medical advice.  Consumers should seal the product in a plastic bag or leak-proof container and check with their local environmental, health, or solid waste agency for proper disposal.  

FDA learned that the product contained mercury from the Arizona Department of Health Services and the Kansas Department of Health and Environment.

More information on topical skin products containing mercury can be found in FDA’s consumer update article, “Mercury Poisoning Linked to Skin Products,” located at: Mercury Poisoning Linked to Skin Products.

Healthcare professionals and patients are encouraged to report any adverse events or side effects potentially related to the use of this product to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Consumers are encouraged to report unlawful sales of products, including “Crema Piel De Seda,” to FDA through our website at: Reporting Unlawful Sales of Medical Products on the Internet.

Cremo Piel De Seda

Page Last Updated: 01/29/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.